Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 0 | 1,602 | 1,580 | 640 |
| Other current assets | 0 | 0 | 0 | 1,710 | 1,290 |
| TOTAL | $0 | $0 | $3,522 | $3,290 | $1,930 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 5 | N/A | N/A |
| Intangibles | 0 | 0 | 3,567 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 5 | 3,585 | 3,515 |
| TOTAL | $N/A | $N/A | $3,576 | $3,585 | $3,515 |
| Total Assets | $0 | $0 | $7,098 | $6,890 | $5,460 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 637 | 680 | 1,080 |
| Accrued Expenses | 0 | 0 | 388 | 340 | 460 |
| TOTAL | $0 | $0 | $3,212 | $3,210 | $3,750 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 100 | 360 | 130 |
| TOTAL | $N/A | $N/A | $100 | $360 | $130 |
| Total Liabilities | $0 | $0 | $3,312 | $3,580 | $3,880 |
| Shareholders' Equity | |||||
| Common Shares | 0 | 0 | 23 | 1,470 | 1,170 |
| Retained earnings | 0 | 0 | -74,426 | -72,430 | -71,440 |
| TOTAL | $0 | $0 | $3,786 | $3,310 | $1,580 |
| Total Liabilities And Equity | $0 | $0 | $7,098 | $6,890 | $5,460 |